Latest Hematologic disease Stories
RnRMarketResearch.com adds "Polycythemia Vera - Pipeline Review, H1 2015" to its store.
To mark National Sickle Cell Month which occurs every September, the Editorial Board of Living with a Disability magazine has published an important new article that sheds light on hematological
PALO ALTO, Calif., April 5, 2011 /PRNewswire/ -- Telik, Inc.
In response to blood cancer re-classifications by the World Health Organization, the MPD Foundation announces it is changing its name to Myeloproliferative Neoplasms (MPN) Research Foundation. Chicago, IL (PRWEB) April 4, 2011 The MPD Foundation, a patient-led foundation dedicated to the discovery of treatments and a cure for three rare blood cancers (myelofibrosis, polycythemia vera, and essential thrombocythemia) announces today a new name for the organization, which will now be known as...
SAN DIEGO, Dec. 3, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, announced the addition of three experienced executives to the management team. John P.
PALO ALTO, Calif., Oct. 26 /PRNewswire/ -- Telik, Inc.
CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that the American Society of Hematology (ASH) has published additional data relating to Soliris(R) (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH).